Login / Signup

Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluation.

Carles Alonso-TarrésCarla Benjumea MorenoCristina MadridAline C HabisonElisenda Gonzàlez-BertranFrancisco BlancoJaume BorràsMontserrat GarrigóJarob Saker
Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)
This first clinical evaluation of the Sysmex PA-100 in a near-patient setting demonstrated that the analyser delivers phenotypic AST results within 45 min, which could enable rapid initiation of the correct targeted treatment with no further adjustment needed. The Sysmex PA-100 has the potential to significantly reduce ineffective or unnecessary antibiotic prescription in patients with UTI symptoms.
Keyphrases
  • clinical evaluation
  • urinary tract infection
  • cancer therapy
  • physical activity
  • risk assessment
  • human health